Your browser doesn't support javascript.
loading
Incidence of Severe COVID-19 Illness Following Vaccination and Booster With BNT162b2, mRNA-1273, and Ad26.COV2.S Vaccines.
Kelly, J Daniel; Leonard, Samuel; Hoggatt, Katherine J; Boscardin, W John; Lum, Emily N; Moss-Vazquez, Tristan A; Andino, Raul; Wong, Joseph K; Byers, Amy; Bravata, Dawn M; Tien, Phyllis C; Keyhani, Salomeh.
Afiliação
  • Kelly JD; San Francisco VA Medical Center, San Francisco, California.
  • Leonard S; Department of Epidemiology and Biostatistics, University of California, San Francisco.
  • Hoggatt KJ; Institute for Global Health Sciences, University of California, San Francisco.
  • Boscardin WJ; F. I. Proctor Foundation, University of California, San Francisco.
  • Lum EN; San Francisco VA Medical Center, San Francisco, California.
  • Moss-Vazquez TA; San Francisco VA Medical Center, San Francisco, California.
  • Andino R; Department of Medicine, University of California, San Francisco.
  • Wong JK; Department of Epidemiology and Biostatistics, University of California, San Francisco.
  • Byers A; San Francisco VA Medical Center, San Francisco, California.
  • Bravata DM; San Francisco VA Medical Center, San Francisco, California.
  • Tien PC; Department of Microbiology and Immunology, University of California, San Francisco.
  • Keyhani S; San Francisco VA Medical Center, San Francisco, California.
JAMA ; 328(14): 1427-1437, 2022 10 11.
Article em En | MEDLINE | ID: mdl-36156706

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Imunização Secundária / COVID-19 / Vacina BNT162 / Vacina de mRNA-1273 contra 2019-nCoV / Ad26COVS1 Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies Limite: Adult / Aged / Female / Humans / Male País/Região como assunto: America do norte Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Imunização Secundária / COVID-19 / Vacina BNT162 / Vacina de mRNA-1273 contra 2019-nCoV / Ad26COVS1 Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies Limite: Adult / Aged / Female / Humans / Male País/Região como assunto: America do norte Idioma: En Ano de publicação: 2022 Tipo de documento: Article